Taysha Gene Therapies, Inc. financial data

Symbol
TSHA on Nasdaq
Location
3000 Pegasus Park Drive, Suite 1430, Dallas, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 447 % +294%
Debt-to-equity 116 %
Return On Equity -27.9 % -103%
Return On Assets -12.9 % +92.4%
Operating Margin -885 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 205M shares +9.62%
Common Stock, Shares, Outstanding 205M shares +9.62%
Entity Public Float 30.4M USD -66.9%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 268M shares +113%
Weighted Average Number of Shares Outstanding, Diluted 268M shares +113%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.92M USD -62.3%
Research and Development Expense 63.4M USD +11.5%
General and Administrative Expense 29M USD -5.3%
Operating Income (Loss) -87.8M USD +20.3%
Nonoperating Income (Expense) 65M USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -22.8M USD +89.4%
Earnings Per Share, Basic 0.34 USD/shares +89.2%
Earnings Per Share, Diluted 0.34 USD/shares +89.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 158M USD -4.01%
Other Assets, Current 465K USD +15.1%
Assets, Current 162M USD -5.97%
Property, Plant and Equipment, Net 7.61M USD -31.8%
Operating Lease, Right-of-Use Asset 8.68M USD -11.9%
Other Assets, Noncurrent 220K USD -27.6%
Assets 180M USD -7.94%
Accounts Payable, Current 4.93M USD -34.4%
Employee-related Liabilities, Current 3.89M USD +41.9%
Liabilities, Current 29.3M USD -83.7%
Operating Lease, Liability, Noncurrent 17.8M USD -7.07%
Other Liabilities, Noncurrent 1.36M USD -64.4%
Liabilities 91.4M USD -62.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.33M USD
Retained Earnings (Accumulated Deficit) -584M USD -4.06%
Stockholders' Equity Attributable to Parent 88.8M USD
Liabilities and Equity 180M USD -7.94%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.8M USD +1.92%
Net Cash Provided by (Used in) Financing Activities -370K USD -246%
Net Cash Provided by (Used in) Investing Activities -140K USD +96.4%
Common Stock, Shares Authorized 400M shares +100%
Common Stock, Shares, Issued 205M shares +9.62%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20M USD +18.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.33M USD +18.1%
Deferred Tax Assets, Valuation Allowance 92M USD -8.94%
Deferred Tax Assets, Gross 94.3M USD -8.86%
Operating Lease, Liability 19.2M USD -5.47%
Depreciation 1.27M USD -5.81%
Payments to Acquire Property, Plant, and Equipment 140K USD -96.4%
Lessee, Operating Lease, Liability, to be Paid 29.1M USD -6.75%
Property, Plant and Equipment, Gross 11.5M USD -16.5%
Operating Lease, Liability, Current 1.43M USD +20.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.49M USD -14.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.91M USD +3.56%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.9M USD -9.14%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.58M USD +3.7%
Deferred Tax Assets, Operating Loss Carryforwards 47.4M USD +3.87%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.67M USD +3.73%
Operating Lease, Payments 2.74M USD +296%
Additional Paid in Capital 675M USD +31.9%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 11.9M USD +18.1%
Interest Expense 2.24M USD -56.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%